Form DEFA14A - Additional definitive proxy soliciting materials and Rule 14(a)(12) material:
SEC Accession No. 0001104659-23-083906
Filing Date
2023-07-25
Accepted
2023-07-25 17:24:06
Documents
2

Document Format Files

Seq Description Document Type Size
1 DEFA14A tm2322064d1_defa14a.htm DEFA14A 18032
2 GRAPHIC tm2322064d1_defa14aimg01.jpg GRAPHIC 6359
  Complete submission text file 0001104659-23-083906.txt   28062
Mailing Address 80 W. LANCASTER AVENUE SUITE 300 DEVON PA 19333
Business Address 80 W. LANCASTER AVENUE SUITE 300 DEVON PA 19333 484-581-7505
Zynerba Pharmaceuticals, Inc. (Filer) CIK: 0001621443 (see all company filings)

EIN.: 260389433 | State of Incorp.: DE | Fiscal Year End: 1231
Type: DEFA14A | Act: 34 | File No.: 001-37526 | Film No.: 231109515
SIC: 2834 Pharmaceutical Preparations